Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02660151Completed
Randomised, open-label trial in corneal edema (2 arms), sponsored by EyeYon Medical. Primary endpoints: Frequency and severity of all treatment-related adverse events at 28 days and Percent of subjects with corneal thickness decrease of at least 8% and or visual acuity improvement of at least 1 line at 28 days. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02660151.